Biotech stories
Sandy Baker appointed independent non-executive director of Stanchion, brings 30+ years experience in finance, governance and impact investing.
Kaspersky launches comprehensive cybersecurity policy to address the security risks posed by human augmentation technology in the workplace.
2020 will go down in history for the year of the global pandemic, but also for the rise of innovative digital technologies.
Greenpeace's Cool IT Leaderboard highlights IT firms' climate efforts. Cisco leads with 62 points, doubling its score through emissions-saving tech.
Mary Alice Simon's appointment is intended to boost production, quality systems and New Zealand's first medicinal cannabis trials.
A waxworm’s gut microbes could help scientists devise ways to break down polyethylene, offering a possible route to curb mounting plastic pollution.
Insect bioconversion could turn millions of tonnes of food waste into animal feed, biodiesel and packaging materials, while cutting emissions.
Pragmatic solutions are needed to cut waste, trim compliance costs and keep safety goals intact as prescriptive rules prove too rigid.
New Zealand's medicinal cannabis sector gains a major research boost as Dr James Polston joins Helius after leading R&D at Trulieve.
With New Zealand aiming to make tech our number two export by 2025, and primary industry already our number one, we need a clear path forward.
Auckland billboards fronted by eight patients and advocates aim to reduce stigma as New Zealand's medicinal cannabis laws take shape.
New Zealand's biotech industry could boost GDP to $182bn in 12 years, says BiotechNZ executive director Dr Zahra Champion.
Public voting is open as finalists for New Zealand’s innovation awards include solar-powered cow collars, quiet drones and Te Reo Maori smartphones.
NZ shares climbed as the NZX 50 Index rose 0.4%, led by Fonterra's rebound from a record low, while Hallenstein Glassons surged 6.5% on robust profit figures.
